Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5292]

Researchers shed light on overcoming cancer drug resistance unlocking potential to expand use of PARP inhibitors across cancer types

Researchers shed light on overcoming cancer drug resistance unlocking potential to expand use of PARP inhibitors...

Demystifying APE1: New findings on direct activation of ATM signalling by DNA single-strand breaks

Demystifying APE1: New findings on direct activation of ATM signalling by DNA single-strand breaks

The battle against glioblastoma: classifying molecular profiles for precision medicine

The battle against glioblastoma: classifying molecular profiles for precision medicine

FDA approves drug targeting Johns Hopkins-discovered brain cancer gene mutation

FDA approves drug targeting Johns Hopkins-discovered brain cancer gene mutation

Targeted cancer therapy: initial high concentration may slow down selection for resistance

Targeted cancer therapy: initial high concentration may slow down selection for resistance

FDA approves daratumumab and hyaluronidase-fihj with bortezomib, lenalidomide, and dexamethasone for multiple myeloma

FDA approves daratumumab and hyaluronidase-fihj with bortezomib, lenalidomide, and dexamethasone for multiple...

FDA grants accelerated approval to afamitresgene autoleucel for unresectable or metastatic synovial sarcoma

FDA grants accelerated approval to afamitresgene autoleucel for unresectable or metastatic synovial sarcoma

First-in-class breast cancer drug approved

First-in-class breast cancer drug approved

FDA-mandated CAR-T monitoring period could be halved

FDA-mandated CAR-T monitoring period could be halved

Blood test may guide use of multiple myeloma immunotherapy

Blood test may guide use of multiple myeloma immunotherapy

More from ecancer